Therapeutic Areas

To date, Coastal Clinical Research, Inc. has conducted over 600 industry-sponsored clinical trials. Our main areas of expertise include:

Cardiovascular
  • Hypertension
  • Post-Stroke
CNS/Neurology
  • Alzheimer’s Disease
  • Diabetic Peripheral Neuropathy
  • Fibromyalgia
  • Gout
  • Headaches/Migraines
  • Post Herpetic Neuralgia
  • Restless Leg Syndrome
  • Sleep Disorders
  • Smoking Cessation
Dermatology
  • Acne
  • Dermatitis
  • Eczema
  • Glabellar Lines
  • Hyperhidrosis
  • Psoriasis
  • Rosacea
  • Seborrheic Keratosis
  • Actinic Keratosis
  • Common Skin Warts
Endocrine & Metabolic Disorders
  • Diabetes
  • Dyslipidemia
  • Hyperlipidemia
  • Obesity
Gastroenterology
  • Constipation
  • Heartburn
Musculo-Skeletal System
  • Osteoarthritis
  • Chronic Lower Back Pain
  • Rheumatoid Arthritis
Urology
  • Benign prostatic hyperplasia (BPH)
  • Erectile Dysfunction
  • Interstitial Cystitis
  • Hypogonadism
  • Nocturia
  • Overactive Bladder
  • Peyronie’s Disease
  • Premature Ejaculation
  • Prostatitis
  • Prostate Cancer
  • Rapid Ejaculation
  • Urinary Incontinence
  • Urinary Tract Infection
Vaccines
  • Seasonal Flu
  • Pandemic Flu
  • Elderly RSV
  • Pediatric
  • Cholera
  • HPV
  • Staphylococcus aureus
  • Meningitis B
  • Dengue Fever 
  • C. Dif
Women’s Health
  • Contraceptives
  • Female Sexual Dysfunction
  • Hypoactive Sexual Desire Disorder
  • Hormone Replacement Therapy
  • Osteoporosis
  • Vasomotor Symptoms in postmenopausal and menopause
  • Vulvovaginal Atrophy/Candidiasis
Other Areas
  • Biomarker
  • Device
  • Diagnostic
  • Healthy Volunteers
  • Nutraceuticals
  • Ophthalmology
  • Over the Counter and Consumer
  • Pediatric trials

For study feasibility inquiries or to find out more information on CCR, contact:
Lauren Garner, CCRC
President
(251) 414-1984
Fax: (251) 414-1985
Laurenb@ccr-research.com


 
CCR Alliance for Multispecialty Research

About CCR

Our mission is to provide our community with the most novel and highest quality research medicines while remaining an efficient and dedicated leader in the pharmaceutical research industry.